Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care
JACC: Advances · 2025-11 · 4 (11) · 102152
DOI: 10.1016/j.jacadv.2025.102152 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Advances, 2025-11. Verfasst von Dor Hadida Barzilai und 6 weiteren Autor:innen. Beteiligte Einrichtung: ARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Ramat Gan, Israel. Electronic address: dorh1994@gmail.com. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Artificial intelligence (AI) has shown promise in transforming health care, particularly in cardiology. However, there is a lack of high-quality evidence demonstrating its impact on crucial clinical outcomes. OBJECTIVES: The purpose of this study was to synthesize existing evidence from randomized controlled trials (RCTs) on the application of AI in cardiology, evaluating its impact on key clinical outcomes. METHODS: We conducted a systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, searching MEDLINE, Web of Science, and the Cochrane Library from inception to November 2024. We included RCTs evaluating machine learning models compared to traditional methods in cardiovascular care. Primary outcomes focused on patient-important metrics, while secondary outcomes covered time and resource savings. RESULTS: Eleven RCTs met the inclusion criteria. Studies were conducted between 2021 and 2024, with 81.2% being multicenter trials. Five studies (45.5%) reported improvements in clinical events, 6 (54.5%) showed enhanced diagnostic accuracy and early detection, and 3 (27.3%) demonstrated improved resource utilization. CONCLUSIONS: This review highlights AI's potential to enhance cardiovascular care through improved early detection, diagnostic accuracy, and resource efficiency. However, the limited number of RCTs indicates a need for more high-quality studies to validate AI's effectiveness across various clinical domains.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Ramat Gan, Israel. Electronic address: dorh1994@gmail.com.
- ARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Ramat Gan, Israel.
- Division of Data-Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- ARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Ramat Gan, Israel; The Sheba Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel; Tel Aviv University, Faculty of Medicine, Tel Aviv, Is…
- Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel; Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.
- ARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Ramat Gan, Israel; Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.
Zitieren
APA
Hadida Barzilai, D., Sudri, K., Goshen, G., Klang, E., Zimlichman, E., Barbash, I., & Cohen Shelly, M. (2025). Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care. JACC: Advances, 4(11), 102152. https://doi.org/10.1016/j.jacadv.2025.102152
Vancouver
Hadida Barzilai D, Sudri K, Goshen G, Klang E, Zimlichman E, Barbash I, et al. Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care. JACC: Advances. 2025;4(11):102152. doi:10.1016/j.jacadv.2025.102152
BibTeX
@article{HadidaBarzilai2025,
author = {Hadida Barzilai, Dor and Sudri, Karin and Goshen, Gal and Klang, Eyal and Zimlichman, Eyal and Barbash, Israel and Cohen Shelly, Michal},
title = {Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care},
journal = {JACC: Advances},
year = {2025},
volume = {4},
number = {11},
pages = {102152},
doi = {10.1016/j.jacadv.2025.102152}
}
EUVIMED